| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/18/2009 | US7575857 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy |
| 08/18/2009 | US7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 08/18/2009 | CA2404616C Use of vegf and homologues to treat neuron disorders |
| 08/18/2009 | CA2365135C Method for amplifying nucleic acid sequence |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/18/2009 | CA2054798C Hcv-specific peptides, agents therefor and the use thereof |
| 08/13/2009 | WO2009100460A1 Systems and methods for measuring the effectiveness of advertising |
| 08/13/2009 | WO2009100430A2 miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
| 08/13/2009 | WO2009100284A2 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 08/13/2009 | WO2009100262A2 Oral care methods and systems |
| 08/13/2009 | WO2009100243A2 Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients |
| 08/13/2009 | WO2009100215A2 Detection of clostridium difficile |
| 08/13/2009 | WO2009100188A2 Methods for detection of corn event das-59132 |
| 08/13/2009 | WO2009100178A2 New brassica ogura restorer lines with shortened raphanus fragment (srf) |
| 08/13/2009 | WO2009100161A2 Epigenetic silencing of mir-342 in colorectal cancer |
| 08/13/2009 | WO2009100159A2 Methods of diagnosing and treating parp-mediated diseases |
| 08/13/2009 | WO2009100141A1 Prediction and diagnosis of canine degenerative myelopathy |
| 08/13/2009 | WO2009100080A1 Composition and method for sequencing nucleic acid |
| 08/13/2009 | WO2009100029A1 Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions |
| 08/13/2009 | WO2009100008A2 Genetic methods for speciating campylobacter |
| 08/13/2009 | WO2009099941A2 Sequences associated with tdp-43 proteinopathies and methods of using the same |
| 08/13/2009 | WO2009099939A2 Systems and methods for ex vivo lung care |
| 08/13/2009 | WO2009099905A2 Molecular signatures and biomarkers associated with melanoma and methods of use thereof |
| 08/13/2009 | WO2009099854A1 Urine transport medium |
| 08/13/2009 | WO2009099643A1 Use of sirt1 activators or inhibitors to modulate an immune response |
| 08/13/2009 | WO2009099642A2 Proteomic analysis of active multiple sclerosis lesions |
| 08/13/2009 | WO2009099603A1 Serum-based, diagnostic, biological assay to predict pregnancy disorders |
| 08/13/2009 | WO2009099602A1 Selection of nucleic acids by solution hybridization to oligonucleotide baits |
| 08/13/2009 | WO2009099555A2 Synthetic surfaces for culturing cells in chemically defined media |
| 08/13/2009 | WO2009099552A2 Cell culture article and screening |
| 08/13/2009 | WO2009099465A2 Methods of using mir-199a as a marker and sequences of mir-199a as a therapeutic for cancer |
| 08/13/2009 | WO2009099378A1 Selection of rna-aptamers as anti-malaria agents |
| 08/13/2009 | WO2009099228A1 Method for prediction and test of heart failure, and reagent and kit for use in the test |
| 08/13/2009 | WO2009099152A1 Cell culture method and screening method |
| 08/13/2009 | WO2009099112A1 Novel dna fragment and use thereof |
| 08/13/2009 | WO2009099073A1 Modified trna containing non-natural nucleotide and use thereof |
| 08/13/2009 | WO2009099037A1 Primer and probe for detecting chlamydophila caviae, as well as a chlamydophila caviae detection method using the same |
| 08/13/2009 | WO2009098998A1 Nucleic acid detection method, and nucleic acid detection kit |
| 08/13/2009 | WO2009098988A1 Sirna detection method |
| 08/13/2009 | WO2009098885A1 Dectin-2 gene-deficient non-human animal |
| 08/13/2009 | WO2009098789A1 Method of detecting pathogenic virus in crustacean by lamp method and reagent kit for detection |
| 08/13/2009 | WO2009098717A2 Method to characterize a protein as rna binding protein |
| 08/13/2009 | WO2009098700A1 Siva 3, its preparation and use |
| 08/13/2009 | WO2009098624A1 Analysis system and method |
| 08/13/2009 | WO2009098485A1 Improvements in and relating to analysis |
| 08/13/2009 | WO2009098451A2 Biomarkers of aminopeptidase inhibition |
| 08/13/2009 | WO2009098313A1 Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate |
| 08/13/2009 | WO2009098298A1 Amplification of bisulfite-reacted nucleic acids |
| 08/13/2009 | WO2009098079A1 Thermo-optical characterisation of nucleic acid molecules |
| 08/13/2009 | WO2009098045A1 Method and kit for detecting, diagnosing or controlling the treatment of ovarian cancer |
| 08/13/2009 | WO2009098039A1 System and method for improved signal detection in nucleic acid sequencing |
| 08/13/2009 | WO2009098038A1 Methods and systems for quality control metrics in hybridization assays |
| 08/13/2009 | WO2009098037A1 Paired end sequencing |
| 08/13/2009 | WO2009098021A1 Selectivity profiling of pi3k interacting molecules against multiple targets |
| 08/13/2009 | WO2009097862A1 Genetic markers for fertility |
| 08/13/2009 | WO2009097692A1 Biomarkers for head-and-neck cancers and precancers |
| 08/13/2009 | WO2009097673A1 Synthesis of single-stranded dna |
| 08/13/2009 | WO2009081291A3 Field effect transistors for detection of nosocomial infection |
| 08/13/2009 | WO2009081261A3 A method and primers for the diagnosis of hereditary haemochromatosis |
| 08/13/2009 | WO2009074364A8 Novel prognostic breast cancer marker |
| 08/13/2009 | WO2009074328A3 Methods and nucleic acids for analyses of lung carcinoma |
| 08/13/2009 | WO2009072009A3 Method for determining the toxicity of a toxin or a toxoid |
| 08/13/2009 | WO2009071301A3 Method for finding effectors of the protease activity of cis/trans-isomerases |
| 08/13/2009 | WO2009067501A3 Infrared thermography for monitoring brown adipose tissue |
| 08/13/2009 | WO2009062081A3 Methods and compositions for antibody or vaccine therapy |
| 08/13/2009 | WO2009062051A3 Methods and compositions for antibody therapy |
| 08/13/2009 | WO2009060124A3 Use of oligonucleotides with modified bases in hybridization of nucleic acids |
| 08/13/2009 | WO2009055616A3 Genetic incorporation of 3-aminotyrosine into reductases |
| 08/13/2009 | WO2009051842A3 Detection of cancer by measuring genomic copy number and strand length in cell-free dna |
| 08/13/2009 | WO2009051803A3 Microarray-based gene copy number analyses |
| 08/13/2009 | WO2009047809A3 Sequence variants for inferring human pigmentation patterns |
| 08/13/2009 | WO2009030908A3 Thermal control apparatus for chemical and biochemical reactions |
| 08/13/2009 | WO2008057613A9 A magnetic resonance system and method to detect and confirm analytes |
| 08/13/2009 | WO2007119165A8 A method for detecting intracytoplasmic protein/protein interactions |
| 08/13/2009 | WO2007105114A8 Methods and compositions for the detection and treatment of cancers |
| 08/13/2009 | WO2004091544A9 Amylases, nucleic acids encoding them and methods for making and using them |
| 08/13/2009 | US20090205082 Rc, Brown Pericarp and Seed Coat |
| 08/13/2009 | US20090205077 Compositions and methods for the modification of gene expression |
| 08/13/2009 | US20090205073 Transgenic plants and methods for controlling bolting in sugar beet |
| 08/13/2009 | US20090205071 a polynucleotide and a genetic vector comprising the polynucleotide, used for introgressing genes into grass plants, so as to provide desirable drought resistant cultivars of plants |
| 08/13/2009 | US20090205066 Fatty acid desaturase genes from plants |
| 08/13/2009 | US20090205061 Taste Receptors Of The T1R Family From Domestic Cat |
| 08/13/2009 | US20090205060 Sesquiterpene synthases from patchouli |
| 08/13/2009 | US20090205056 Method of screening for modulators of map3k11 in liver cancer cells |
| 08/13/2009 | US20090204489 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 08/13/2009 | US20090204379 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
| 08/13/2009 | US20090204334 Lung cancer biomarkers |
| 08/13/2009 | US20090204333 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| 08/13/2009 | US20090203895 siRNA targeting cyclin-dependent kinase 4 (CDK4) |
| 08/13/2009 | US20090203885 Astrocyte Modulated Genes And Uses Thereof |
| 08/13/2009 | US20090203878 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 08/13/2009 | US20090203790 Gamma-l-pga producing microorganism, method of producing gamma-l-pga using the microorganism, crosslinked substance produced using the microorganism, and external dermal agent produced using the microorganism |
| 08/13/2009 | US20090203770 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS |
| 08/13/2009 | US20090203749 Agent for control of degranulation reaction and cytokine production |
| 08/13/2009 | US20090203728 Naphthalamide derivatives having antiproliferative activity |
| 08/13/2009 | US20090203720 Methods for inhibiting cell growth |
| 08/13/2009 | US20090203641 Antibiotic compositions and related screening methods |
| 08/13/2009 | US20090203639 Methylation Markers for Diagnoses and Treatment of Cancers |
| 08/13/2009 | US20090203635 HXAAA01 Polynucleotides |
| 08/13/2009 | US20090203618 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |